5-Amino-1MQ
aka 5-Amino-1-methylquinolinium
GLP-1 / Metabolic
Mechanism
5-Amino-1MQ is a small heterocyclic molecule (not a peptide) that acts as a selective, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). It is under preclinical investigation for obesity and non-alcoholic fatty liver disease. It is not FDA-approved and has not completed human clinical trials; it is commonly tracked alongside peptides because grey-market vendors sell it for metabolic protocols.
Identification
Vendors selling 5-Amino-1MQ
No vendor listings on file yet.
Research
No citations on file yet.